Medical Care
Global THR- β Agonists Market Research Report 2025
- May 12, 25
- ID: 235244
- Pages: 67
- Figures: 67
- Views: 6
The global market for THR- β Agonists was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
THR-β (thyroid hormone receptor-beta) agonists are a class of compounds that activate the thyroid hormone receptor-beta, a nuclear receptor involved in regulating gene expression. These agonists bind to the THR-β receptor and stimulate its activity, leading to various physiological effects.
North American market for THR- β Agonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for THR- β Agonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for THR- β Agonists in Metabolic Diseases is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of THR- β Agonists include Madrigal Pharmaceuticals, Terns Pharmaceuticals, Ascletis, Haisco Pharmaceutical Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for THR- β Agonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding THR- β Agonists.
The THR- β Agonists market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global THR- β Agonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the THR- β Agonists companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Madrigal Pharmaceuticals
Terns Pharmaceuticals
Ascletis
Haisco Pharmaceutical Group
Segment by Type
Specification Below 10mg
Specification 10-50mg
Specification Above 50mg
Segment by Application
Metabolic Diseases
Cardiovascular Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of THR- β Agonists company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
THR-β (thyroid hormone receptor-beta) agonists are a class of compounds that activate the thyroid hormone receptor-beta, a nuclear receptor involved in regulating gene expression. These agonists bind to the THR-β receptor and stimulate its activity, leading to various physiological effects.
North American market for THR- β Agonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for THR- β Agonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for THR- β Agonists in Metabolic Diseases is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of THR- β Agonists include Madrigal Pharmaceuticals, Terns Pharmaceuticals, Ascletis, Haisco Pharmaceutical Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for THR- β Agonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding THR- β Agonists.
The THR- β Agonists market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global THR- β Agonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the THR- β Agonists companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Madrigal Pharmaceuticals
Terns Pharmaceuticals
Ascletis
Haisco Pharmaceutical Group
Segment by Type
Specification Below 10mg
Specification 10-50mg
Specification Above 50mg
Segment by Application
Metabolic Diseases
Cardiovascular Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of THR- β Agonists company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global THR- β Agonists Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Specification Below 10mg
1.2.3 Specification 10-50mg
1.2.4 Specification Above 50mg
1.3 Market by Application
1.3.1 Global THR- β Agonists Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Metabolic Diseases
1.3.3 Cardiovascular Disease
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global THR- β Agonists Market Perspective (2020-2031)
2.2 Global THR- β Agonists Growth Trends by Region
2.2.1 Global THR- β Agonists Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 THR- β Agonists Historic Market Size by Region (2020-2025)
2.2.3 THR- β Agonists Forecasted Market Size by Region (2026-2031)
2.3 THR- β Agonists Market Dynamics
2.3.1 THR- β Agonists Industry Trends
2.3.2 THR- β Agonists Market Drivers
2.3.3 THR- β Agonists Market Challenges
2.3.4 THR- β Agonists Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top THR- β Agonists Players by Revenue
3.1.1 Global Top THR- β Agonists Players by Revenue (2020-2025)
3.1.2 Global THR- β Agonists Revenue Market Share by Players (2020-2025)
3.2 Global THR- β Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by THR- β Agonists Revenue
3.4 Global THR- β Agonists Market Concentration Ratio
3.4.1 Global THR- β Agonists Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by THR- β Agonists Revenue in 2024
3.5 Global Key Players of THR- β Agonists Head office and Area Served
3.6 Global Key Players of THR- β Agonists, Product and Application
3.7 Global Key Players of THR- β Agonists, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 THR- β Agonists Breakdown Data by Type
4.1 Global THR- β Agonists Historic Market Size by Type (2020-2025)
4.2 Global THR- β Agonists Forecasted Market Size by Type (2026-2031)
5 THR- β Agonists Breakdown Data by Application
5.1 Global THR- β Agonists Historic Market Size by Application (2020-2025)
5.2 Global THR- β Agonists Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America THR- β Agonists Market Size (2020-2031)
6.2 North America THR- β Agonists Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America THR- β Agonists Market Size by Country (2020-2025)
6.4 North America THR- β Agonists Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe THR- β Agonists Market Size (2020-2031)
7.2 Europe THR- β Agonists Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe THR- β Agonists Market Size by Country (2020-2025)
7.4 Europe THR- β Agonists Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific THR- β Agonists Market Size (2020-2031)
8.2 Asia-Pacific THR- β Agonists Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific THR- β Agonists Market Size by Region (2020-2025)
8.4 Asia-Pacific THR- β Agonists Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America THR- β Agonists Market Size (2020-2031)
9.2 Latin America THR- β Agonists Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America THR- β Agonists Market Size by Country (2020-2025)
9.4 Latin America THR- β Agonists Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa THR- β Agonists Market Size (2020-2031)
10.2 Middle East & Africa THR- β Agonists Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa THR- β Agonists Market Size by Country (2020-2025)
10.4 Middle East & Africa THR- β Agonists Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Madrigal Pharmaceuticals
11.1.1 Madrigal Pharmaceuticals Company Details
11.1.2 Madrigal Pharmaceuticals Business Overview
11.1.3 Madrigal Pharmaceuticals THR- β Agonists Introduction
11.1.4 Madrigal Pharmaceuticals Revenue in THR- β Agonists Business (2020-2025)
11.1.5 Madrigal Pharmaceuticals Recent Development
11.2 Terns Pharmaceuticals
11.2.1 Terns Pharmaceuticals Company Details
11.2.2 Terns Pharmaceuticals Business Overview
11.2.3 Terns Pharmaceuticals THR- β Agonists Introduction
11.2.4 Terns Pharmaceuticals Revenue in THR- β Agonists Business (2020-2025)
11.2.5 Terns Pharmaceuticals Recent Development
11.3 Ascletis
11.3.1 Ascletis Company Details
11.3.2 Ascletis Business Overview
11.3.3 Ascletis THR- β Agonists Introduction
11.3.4 Ascletis Revenue in THR- β Agonists Business (2020-2025)
11.3.5 Ascletis Recent Development
11.4 Haisco Pharmaceutical Group
11.4.1 Haisco Pharmaceutical Group Company Details
11.4.2 Haisco Pharmaceutical Group Business Overview
11.4.3 Haisco Pharmaceutical Group THR- β Agonists Introduction
11.4.4 Haisco Pharmaceutical Group Revenue in THR- β Agonists Business (2020-2025)
11.4.5 Haisco Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global THR- β Agonists Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Specification Below 10mg
1.2.3 Specification 10-50mg
1.2.4 Specification Above 50mg
1.3 Market by Application
1.3.1 Global THR- β Agonists Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Metabolic Diseases
1.3.3 Cardiovascular Disease
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global THR- β Agonists Market Perspective (2020-2031)
2.2 Global THR- β Agonists Growth Trends by Region
2.2.1 Global THR- β Agonists Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 THR- β Agonists Historic Market Size by Region (2020-2025)
2.2.3 THR- β Agonists Forecasted Market Size by Region (2026-2031)
2.3 THR- β Agonists Market Dynamics
2.3.1 THR- β Agonists Industry Trends
2.3.2 THR- β Agonists Market Drivers
2.3.3 THR- β Agonists Market Challenges
2.3.4 THR- β Agonists Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top THR- β Agonists Players by Revenue
3.1.1 Global Top THR- β Agonists Players by Revenue (2020-2025)
3.1.2 Global THR- β Agonists Revenue Market Share by Players (2020-2025)
3.2 Global THR- β Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by THR- β Agonists Revenue
3.4 Global THR- β Agonists Market Concentration Ratio
3.4.1 Global THR- β Agonists Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by THR- β Agonists Revenue in 2024
3.5 Global Key Players of THR- β Agonists Head office and Area Served
3.6 Global Key Players of THR- β Agonists, Product and Application
3.7 Global Key Players of THR- β Agonists, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 THR- β Agonists Breakdown Data by Type
4.1 Global THR- β Agonists Historic Market Size by Type (2020-2025)
4.2 Global THR- β Agonists Forecasted Market Size by Type (2026-2031)
5 THR- β Agonists Breakdown Data by Application
5.1 Global THR- β Agonists Historic Market Size by Application (2020-2025)
5.2 Global THR- β Agonists Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America THR- β Agonists Market Size (2020-2031)
6.2 North America THR- β Agonists Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America THR- β Agonists Market Size by Country (2020-2025)
6.4 North America THR- β Agonists Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe THR- β Agonists Market Size (2020-2031)
7.2 Europe THR- β Agonists Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe THR- β Agonists Market Size by Country (2020-2025)
7.4 Europe THR- β Agonists Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific THR- β Agonists Market Size (2020-2031)
8.2 Asia-Pacific THR- β Agonists Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific THR- β Agonists Market Size by Region (2020-2025)
8.4 Asia-Pacific THR- β Agonists Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America THR- β Agonists Market Size (2020-2031)
9.2 Latin America THR- β Agonists Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America THR- β Agonists Market Size by Country (2020-2025)
9.4 Latin America THR- β Agonists Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa THR- β Agonists Market Size (2020-2031)
10.2 Middle East & Africa THR- β Agonists Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa THR- β Agonists Market Size by Country (2020-2025)
10.4 Middle East & Africa THR- β Agonists Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Madrigal Pharmaceuticals
11.1.1 Madrigal Pharmaceuticals Company Details
11.1.2 Madrigal Pharmaceuticals Business Overview
11.1.3 Madrigal Pharmaceuticals THR- β Agonists Introduction
11.1.4 Madrigal Pharmaceuticals Revenue in THR- β Agonists Business (2020-2025)
11.1.5 Madrigal Pharmaceuticals Recent Development
11.2 Terns Pharmaceuticals
11.2.1 Terns Pharmaceuticals Company Details
11.2.2 Terns Pharmaceuticals Business Overview
11.2.3 Terns Pharmaceuticals THR- β Agonists Introduction
11.2.4 Terns Pharmaceuticals Revenue in THR- β Agonists Business (2020-2025)
11.2.5 Terns Pharmaceuticals Recent Development
11.3 Ascletis
11.3.1 Ascletis Company Details
11.3.2 Ascletis Business Overview
11.3.3 Ascletis THR- β Agonists Introduction
11.3.4 Ascletis Revenue in THR- β Agonists Business (2020-2025)
11.3.5 Ascletis Recent Development
11.4 Haisco Pharmaceutical Group
11.4.1 Haisco Pharmaceutical Group Company Details
11.4.2 Haisco Pharmaceutical Group Business Overview
11.4.3 Haisco Pharmaceutical Group THR- β Agonists Introduction
11.4.4 Haisco Pharmaceutical Group Revenue in THR- β Agonists Business (2020-2025)
11.4.5 Haisco Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global THR- β Agonists Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Specification Below 10mg
Table 3. Key Players of Specification 10-50mg
Table 4. Key Players of Specification Above 50mg
Table 5. Global THR- β Agonists Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global THR- β Agonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global THR- β Agonists Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global THR- β Agonists Market Share by Region (2020-2025)
Table 9. Global THR- β Agonists Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global THR- β Agonists Market Share by Region (2026-2031)
Table 11. THR- β Agonists Market Trends
Table 12. THR- β Agonists Market Drivers
Table 13. THR- β Agonists Market Challenges
Table 14. THR- β Agonists Market Restraints
Table 15. Global THR- β Agonists Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global THR- β Agonists Market Share by Players (2020-2025)
Table 17. Global Top THR- β Agonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in THR- β Agonists as of 2024)
Table 18. Ranking of Global Top THR- β Agonists Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by THR- β Agonists Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of THR- β Agonists, Headquarters and Area Served
Table 21. Global Key Players of THR- β Agonists, Product and Application
Table 22. Global Key Players of THR- β Agonists, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global THR- β Agonists Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global THR- β Agonists Revenue Market Share by Type (2020-2025)
Table 26. Global THR- β Agonists Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global THR- β Agonists Revenue Market Share by Type (2026-2031)
Table 28. Global THR- β Agonists Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global THR- β Agonists Revenue Market Share by Application (2020-2025)
Table 30. Global THR- β Agonists Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global THR- β Agonists Revenue Market Share by Application (2026-2031)
Table 32. North America THR- β Agonists Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America THR- β Agonists Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America THR- β Agonists Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe THR- β Agonists Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe THR- β Agonists Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe THR- β Agonists Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific THR- β Agonists Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific THR- β Agonists Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific THR- β Agonists Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America THR- β Agonists Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America THR- β Agonists Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America THR- β Agonists Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa THR- β Agonists Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa THR- β Agonists Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa THR- β Agonists Market Size by Country (2026-2031) & (US$ Million)
Table 47. Madrigal Pharmaceuticals Company Details
Table 48. Madrigal Pharmaceuticals Business Overview
Table 49. Madrigal Pharmaceuticals THR- β Agonists Product
Table 50. Madrigal Pharmaceuticals Revenue in THR- β Agonists Business (2020-2025) & (US$ Million)
Table 51. Madrigal Pharmaceuticals Recent Development
Table 52. Terns Pharmaceuticals Company Details
Table 53. Terns Pharmaceuticals Business Overview
Table 54. Terns Pharmaceuticals THR- β Agonists Product
Table 55. Terns Pharmaceuticals Revenue in THR- β Agonists Business (2020-2025) & (US$ Million)
Table 56. Terns Pharmaceuticals Recent Development
Table 57. Ascletis Company Details
Table 58. Ascletis Business Overview
Table 59. Ascletis THR- β Agonists Product
Table 60. Ascletis Revenue in THR- β Agonists Business (2020-2025) & (US$ Million)
Table 61. Ascletis Recent Development
Table 62. Haisco Pharmaceutical Group Company Details
Table 63. Haisco Pharmaceutical Group Business Overview
Table 64. Haisco Pharmaceutical Group THR- β Agonists Product
Table 65. Haisco Pharmaceutical Group Revenue in THR- β Agonists Business (2020-2025) & (US$ Million)
Table 66. Haisco Pharmaceutical Group Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
Table 70. Authors List of This Report
List of Figures
Figure 1. THR- β Agonists Picture
Figure 2. Global THR- β Agonists Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global THR- β Agonists Market Share by Type: 2024 VS 2031
Figure 4. Specification Below 10mg Features
Figure 5. Specification 10-50mg Features
Figure 6. Specification Above 50mg Features
Figure 7. Global THR- β Agonists Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global THR- β Agonists Market Share by Application: 2024 VS 2031
Figure 9. Metabolic Diseases Case Studies
Figure 10. Cardiovascular Disease Case Studies
Figure 11. Others Case Studies
Figure 12. THR- β Agonists Report Years Considered
Figure 13. Global THR- β Agonists Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global THR- β Agonists Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global THR- β Agonists Market Share by Region: 2024 VS 2031
Figure 16. Global THR- β Agonists Market Share by Players in 2024
Figure 17. Global Top THR- β Agonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in THR- β Agonists as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by THR- β Agonists Revenue in 2024
Figure 19. North America THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America THR- β Agonists Market Share by Country (2020-2031)
Figure 21. United States THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe THR- β Agonists Market Share by Country (2020-2031)
Figure 25. Germany THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific THR- β Agonists Market Share by Region (2020-2031)
Figure 33. China THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America THR- β Agonists Market Share by Country (2020-2031)
Figure 41. Mexico THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa THR- β Agonists Market Share by Country (2020-2031)
Figure 45. Turkey THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Madrigal Pharmaceuticals Revenue Growth Rate in THR- β Agonists Business (2020-2025)
Figure 49. Terns Pharmaceuticals Revenue Growth Rate in THR- β Agonists Business (2020-2025)
Figure 50. Ascletis Revenue Growth Rate in THR- β Agonists Business (2020-2025)
Figure 51. Haisco Pharmaceutical Group Revenue Growth Rate in THR- β Agonists Business (2020-2025)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Table 1. Global THR- β Agonists Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Specification Below 10mg
Table 3. Key Players of Specification 10-50mg
Table 4. Key Players of Specification Above 50mg
Table 5. Global THR- β Agonists Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global THR- β Agonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global THR- β Agonists Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global THR- β Agonists Market Share by Region (2020-2025)
Table 9. Global THR- β Agonists Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global THR- β Agonists Market Share by Region (2026-2031)
Table 11. THR- β Agonists Market Trends
Table 12. THR- β Agonists Market Drivers
Table 13. THR- β Agonists Market Challenges
Table 14. THR- β Agonists Market Restraints
Table 15. Global THR- β Agonists Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global THR- β Agonists Market Share by Players (2020-2025)
Table 17. Global Top THR- β Agonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in THR- β Agonists as of 2024)
Table 18. Ranking of Global Top THR- β Agonists Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by THR- β Agonists Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of THR- β Agonists, Headquarters and Area Served
Table 21. Global Key Players of THR- β Agonists, Product and Application
Table 22. Global Key Players of THR- β Agonists, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global THR- β Agonists Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global THR- β Agonists Revenue Market Share by Type (2020-2025)
Table 26. Global THR- β Agonists Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global THR- β Agonists Revenue Market Share by Type (2026-2031)
Table 28. Global THR- β Agonists Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global THR- β Agonists Revenue Market Share by Application (2020-2025)
Table 30. Global THR- β Agonists Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global THR- β Agonists Revenue Market Share by Application (2026-2031)
Table 32. North America THR- β Agonists Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America THR- β Agonists Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America THR- β Agonists Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe THR- β Agonists Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe THR- β Agonists Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe THR- β Agonists Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific THR- β Agonists Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific THR- β Agonists Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific THR- β Agonists Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America THR- β Agonists Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America THR- β Agonists Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America THR- β Agonists Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa THR- β Agonists Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa THR- β Agonists Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa THR- β Agonists Market Size by Country (2026-2031) & (US$ Million)
Table 47. Madrigal Pharmaceuticals Company Details
Table 48. Madrigal Pharmaceuticals Business Overview
Table 49. Madrigal Pharmaceuticals THR- β Agonists Product
Table 50. Madrigal Pharmaceuticals Revenue in THR- β Agonists Business (2020-2025) & (US$ Million)
Table 51. Madrigal Pharmaceuticals Recent Development
Table 52. Terns Pharmaceuticals Company Details
Table 53. Terns Pharmaceuticals Business Overview
Table 54. Terns Pharmaceuticals THR- β Agonists Product
Table 55. Terns Pharmaceuticals Revenue in THR- β Agonists Business (2020-2025) & (US$ Million)
Table 56. Terns Pharmaceuticals Recent Development
Table 57. Ascletis Company Details
Table 58. Ascletis Business Overview
Table 59. Ascletis THR- β Agonists Product
Table 60. Ascletis Revenue in THR- β Agonists Business (2020-2025) & (US$ Million)
Table 61. Ascletis Recent Development
Table 62. Haisco Pharmaceutical Group Company Details
Table 63. Haisco Pharmaceutical Group Business Overview
Table 64. Haisco Pharmaceutical Group THR- β Agonists Product
Table 65. Haisco Pharmaceutical Group Revenue in THR- β Agonists Business (2020-2025) & (US$ Million)
Table 66. Haisco Pharmaceutical Group Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
Table 70. Authors List of This Report
List of Figures
Figure 1. THR- β Agonists Picture
Figure 2. Global THR- β Agonists Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global THR- β Agonists Market Share by Type: 2024 VS 2031
Figure 4. Specification Below 10mg Features
Figure 5. Specification 10-50mg Features
Figure 6. Specification Above 50mg Features
Figure 7. Global THR- β Agonists Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global THR- β Agonists Market Share by Application: 2024 VS 2031
Figure 9. Metabolic Diseases Case Studies
Figure 10. Cardiovascular Disease Case Studies
Figure 11. Others Case Studies
Figure 12. THR- β Agonists Report Years Considered
Figure 13. Global THR- β Agonists Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global THR- β Agonists Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global THR- β Agonists Market Share by Region: 2024 VS 2031
Figure 16. Global THR- β Agonists Market Share by Players in 2024
Figure 17. Global Top THR- β Agonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in THR- β Agonists as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by THR- β Agonists Revenue in 2024
Figure 19. North America THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America THR- β Agonists Market Share by Country (2020-2031)
Figure 21. United States THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe THR- β Agonists Market Share by Country (2020-2031)
Figure 25. Germany THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific THR- β Agonists Market Share by Region (2020-2031)
Figure 33. China THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America THR- β Agonists Market Share by Country (2020-2031)
Figure 41. Mexico THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa THR- β Agonists Market Share by Country (2020-2031)
Figure 45. Turkey THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE THR- β Agonists Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Madrigal Pharmaceuticals Revenue Growth Rate in THR- β Agonists Business (2020-2025)
Figure 49. Terns Pharmaceuticals Revenue Growth Rate in THR- β Agonists Business (2020-2025)
Figure 50. Ascletis Revenue Growth Rate in THR- β Agonists Business (2020-2025)
Figure 51. Haisco Pharmaceutical Group Revenue Growth Rate in THR- β Agonists Business (2020-2025)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232